Meclon Pharmaceuticals Private Limited, a active private limited company, was established on 01 January 2016 in Bangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230KA2016PTC085079. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Shylaja Dharmegowda Sabbanahalli (Director), Dharme Gowda Nidhi (Director). Past directors included Venugopal Reddy Venkatarama Reddy, Krishnan Devaraj, Krishnamurthy Ramesh. Its latest AGM occurred on 01 December 2023, with the balance sheet filed on 31 March 2023. It is based at House No. 356 And 395, 11Th Block, Ward No 73, Kottigepalya, Nagarabhavi 2Nd Stage,, Bangalore, Karnataka, 560072.
U24230KA2016PTC085079
085079
01 January 2016
₹1.00 M
₹0.50 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Meclon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shylaja Dharmegowda Sabbanahalli | Director | 27 Apr 2021 | Current |
| Dharme Gowda Nidhi | Director | 15 Jun 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Jul 2020 | Past |
| Pramod Abcsdd | Director | 25 Aug 2016 | Past |
| Pramod Abcsdd | Additional Director | 09 Mar 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2017 | Past |
| Pramod Abcsdd | Director | 09 Mar 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Meclon Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 66.98% increase. The company also saw a substantial fall in profitability, with a 27.44% decrease in profit. The company's net worth dipped by a decrease of 7.21%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Meclon Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Meclon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Meclon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meclon Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Meclon Pharmaceuticals Private Limited last Annual general meeting of members was held on 01 Dec 2023 as per latest MCA records. was completed.
The activity Meclon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore. was completed.
Dharme Gowda Nidhi was appointed as a Director was appointed as a Director on 15 Jun 2021 & has been associated with this company since 4 years 5 months . was recorded as a recent event.
Progress on Shylaja Dharmegowda Sabbanahalli was appointed as a Director was appointed as a Director on 27 Apr 2021 & has been associated with this company since 4 years 7 months . was documented.
Progress on Meclon Pharmaceuticals Private Limited was registered on 01 Jan 2016 with Roc Bangalore & aged 9 years 10 months as per MCA records. was documented.
The CIN of Meclon Pharmaceuticals Private Limited is U24230KA2016PTC085079.
Meclon Pharmaceuticals Private Limited is headquartered at House No. 356 And 395, 11Th Block, Ward No 73, Kottigepalya, Nagarabhavi 2Nd Stage,, Bangalore, Karnataka, 560072.
Meclon Pharmaceuticals Private Limited was incorporated on 01 January 2016.
The current directors of Meclon Pharmaceuticals Private Limited are
The primary industry of Meclon Pharmaceuticals Private Limited is Trade.
Meclon Pharmaceuticals Private Limited is unlisted.
The authorized capital of Meclon Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Meclon Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX